These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33836519)

  • 1. Bioengineered
    Fernández-Garibay X; Ortega MA; Cerro-Herreros E; Comelles J; Martínez E; Artero R; Fernández-Costa JM; Ramón-Azcón J
    Biofabrication; 2021 Apr; 13(3):. PubMed ID: 33836519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
    Mondragon-Gonzalez R; Perlingeiro RCR
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of quantitative and consistent in vitro skeletal muscle pathological models of myotonic dystrophy type 1 using patient-derived iPSCs.
    Kawada R; Jonouchi T; Kagita A; Sato M; Hotta A; Sakurai H
    Sci Rep; 2023 Jan; 13(1):94. PubMed ID: 36631509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts.
    Pantic B; Borgia D; Giunco S; Malena A; Kiyono T; Salvatori S; De Rossi A; Giardina E; Sangiuolo F; Pegoraro E; Vergani L; Botta A
    Exp Cell Res; 2016 Mar; 342(1):39-51. PubMed ID: 26905645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staufen1 impairs stress granule formation in skeletal muscle cells from myotonic dystrophy type 1 patients.
    Ravel-Chapuis A; Klein Gunnewiek A; Bélanger G; Crawford Parks TE; Côté J; Jasmin BJ
    Mol Biol Cell; 2016 Jun; 27(11):1728-39. PubMed ID: 27030674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblasts.
    Tajhya RB; Hu X; Tanner MR; Huq R; Kongchan N; Neilson JR; Rodney GG; Horrigan FT; Timchenko LT; Beeton C
    Cell Death Dis; 2016 Oct; 7(10):e2426. PubMed ID: 27763639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal nuclear aggregation and myotube degeneration in myotonic dystrophy type 1.
    Wang Y; Hao L; Li H; Cleary JD; Tomac MP; Thapa A; Guo X; Zeng D; Wang H; McRae M; Jastrzemski O; Smith-Fassler AM; Xu Y; Xia G
    Neurol Sci; 2019 Jun; 40(6):1255-1265. PubMed ID: 30891637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of Micromolded Gelatin Hydrogels for Long-Term Culture of Aligned Skeletal Myotubes.
    Suh GC; Bettadapur A; Santoso JW; McCain ML
    Methods Mol Biol; 2017; 1668():147-163. PubMed ID: 28842908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Culture of Aligned Skeletal Myotubes on Micromolded Gelatin Hydrogels.
    Bettadapur A; Suh GC; Geisse NA; Wang ER; Hua C; Huber HA; Viscio AA; Kim JY; Strickland JB; McCain ML
    Sci Rep; 2016 Jun; 6():28855. PubMed ID: 27350122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction.
    Renna LV; Cardani R; Botta A; Rossi G; Fossati B; Costa E; Meola G
    Eur J Histochem; 2014 Oct; 58(4):2444. PubMed ID: 25578974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts.
    Beffy P; Del Carratore R; Masini M; Furling D; Puymirat J; Masiello P; Simili M
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1973-83. PubMed ID: 20797447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.
    Furling D; Lemieux D; Taneja K; Puymirat J
    Neuromuscul Disord; 2001 Nov; 11(8):728-35. PubMed ID: 11595515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering a 3D in vitro model of human skeletal muscle at the single fiber scale.
    Urciuolo A; Serena E; Ghua R; Zatti S; Giomo M; Mattei N; Vetralla M; Selmin G; Luni C; Vitulo N; Valle G; Vitiello L; Elvassore N
    PLoS One; 2020; 15(5):e0232081. PubMed ID: 32374763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes.
    Santoro M; Piacentini R; Masciullo M; Bianchi ML; Modoni A; Podda MV; Ricci E; Silvestri G; Grassi C
    Neuropathol Appl Neurobiol; 2014 Jun; 40(4):464-76. PubMed ID: 23888875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome Analysis in a Primary Human Muscle Cell Differentiation Model for Myotonic Dystrophy Type 1.
    Todorow V; Hintze S; Kerr ARW; Hehr A; Schoser B; Meinke P
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy.
    Cerro-Herreros E; González-Martínez I; Moreno-Cervera N; Overby S; Pérez-Alonso M; Llamusí B; Artero R
    Mol Ther Nucleic Acids; 2020 Sep; 21():837-849. PubMed ID: 32805487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.